A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cysteamine
Buflomedil
The risk or severity of hypertension can be increased when Clomipramine is combined with Buflomedil.
Cysteamine
Xenon
The risk or severity of hypertension can be increased when Clomipramine is combined with Xenon.
Cysteamine
Fenozolone
The risk or severity of hypertension can be increased when Clomipramine is combined with Fenozolone.
Cysteamine
Tramazoline
The risk or severity of hypertension can be increased when Clomipramine is combined with Tramazoline.
Cysteamine
Ebselen
The risk or severity of hypertension can be increased when Clomipramine is combined with Ebselen.
Cysteamine
Idazoxan
The risk or severity of hypertension can be increased when Clomipramine is combined with Idazoxan.
Cysteamine
Atipamezole
The risk or severity of hypertension can be increased when Clomipramine is combined with Atipamezole.
Cysteamine
Tyramine
The risk or severity of hypertension can be increased when Clomipramine is combined with Tyramine.
Cysteamine
Saralasin
The risk or severity of hypertension can be increased when Clomipramine is combined with Saralasin.
Cysteamine
1-benzylimidazole
The risk or severity of hypertension can be increased when Clomipramine is combined with 1-benzylimidazole.
Cysteamine
Taxifolin
The risk or severity of hypertension can be increased when Clomipramine is combined with Taxifolin.
Cysteamine
Epicaptopril
The risk or severity of hypertension can be increased when Clomipramine is combined with Epicaptopril.
Cysteamine
Dabrafenib
The serum concentration of Clomipramine can be decreased when it is combined with Dabrafenib.
Cysteamine
Thalidomide
Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cysteamine
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Cysteamine
Suvorexant
Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Cysteamine
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Cysteamine
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Clomipramine.
Cysteamine
Rotigotine
Clomipramine may increase the sedative activities of Rotigotine.
Cysteamine
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3